The implantable cardioverter-defibrillator (ICD) that saved Christian Eriksen’s life during Denmark’s Euro 2020 match against Finland has been hailed as a medical triumph. The device, which delivers an electric shock to restore normal heart rhythm, was fitted after the midfielder suffered a cardiac arrest on the pitch in June 2021. Eriksen’s return to professional football last February, wearing the device, was celebrated as a testament to modern medicine and athletic resilience. However, his case has reignited debate over the safety of competitive sport for athletes with ICDs, particularly in high-intensity environments.
Medical experts stress that ICDs are designed to prevent sudden cardiac death, but they are not foolproof. The device can malfunction, and the physical demands of elite sport may increase the risk of lead fracture or inappropriate shocks. Eriksen’s recovery and subsequent performances for Brentford and Denmark have been closely monitored by cardiologists. Yet, the long-term prognosis for athletes with ICDs remains uncertain. Regulatory bodies, including FIFA and UEFA, are reviewing protocols for managing cardiac events, but critics argue that more stringent screening and mandatory defibrillator access at all matches are needed.
Eriksen’s case also highlights the psychological burden on players. The constant awareness of a life-saving device implanted beneath the skin can affect mental wellbeing. For the sport, the question is whether the benefits of allowing such players to compete outweigh the risks. As Eriksen continues to play at the highest level, his story remains a powerful reminder of both the progress and the perils of medical interventions in sport.
